Cirrhosis/Liver Failure News

VIENNA — A number of patients with alcohol-related cirrhosis developed hepatocellular carcinoma and other complications over time, regardless of alcohol and tobacco consumption, according to data presented at the 2015 International Liver Congress.

VIENNA — Gut decontamination combination therapy with propranolol and rifaximin greatly reduced hepatic venous pressure gradient in patients with cirrhosis vs. propranolol monotherapy, according to data presented at the 2015 International Liver Congress.

VIENNA — Exome sequencing of liver tumors was found to be effective in determining relationships between environmental exposures and mutation signatures, which may assist in determining therapy for patients with hepatocellular carcinoma in the future, according to data presented at a press conference at the 2015 International Liver Congress.

In a new study, alpha-fetoprotein measurement in combination with ultrasound improved surveillance effectiveness in patients with cirrhosis, according to published data in The American Journal of Gastroenterology.

In a new study, researchers found that men who drink and had a father who had alcohol problems or died from liver disease had increased odds for developing cirrhosis.

In a new study, assessing frailty at hospital admission accurately predicted 90-day survival in patients with cirrhosis, according to published data in Hepatology.

Quality of care indicators for decompensated cirrhosis were below standard levels among hospitalized patients at University of Vermont Medical Center, according to study data.

Combination therapy of bezafibrate and ursodeoxycholic acid was more effective in lowering alkaline phosphatase levels vs. monotherapy with ursodeoxycholic acid among a cohort of patients with primary biliary cirrhosis, according to study data.

Alcoholic hepatitis was prevalent in patients with gastrointestinal bleeding, and alcoholic cirrhosis, but survival was similar with and without gastrointestinal bleeding, according to study data.

An MRI was effective in measuring primary biliary cirrhosis, or PBC, in Chinese adults, according to study data.